Performance Measurement Network

Question: what if Pradaxa (dabigatran) is prescribed at discharge?

This is follow up to a prior question: "Pradaxa (dabigatran) prescribed at discharge";.

May we select 'Yes' for both Antithrombotic and Anticoagulant Therapy Prescribed at Discharge, if Pradaxa is prescribed at discharge? Does addition of Pradax to Appendix C, Table 8.2 Antithrombotic Medications-Stroke apply to 2011 discharges or 2012 discharges?


Stroke data are "Collected for The Joint Commission Only" and not submitted to CMS (i.e., "CMS Information Only"). You may select 'Yes' now for STK-2 and STK-3, if Pradaxa is prescribed at discharge; however, the change will not appear in print until the Jan 1, 2012 manual. CMS declined our request to add an addendum for Pradaxa to the current specifications manual.

Question Details
Focus area(s): Chart Abstracted Measure Specifications – Clinical
Related documents: STK-02,

Copyright © by the contributing authors. All material on this collaboration platform is the property of the contributing authors.
Ideas, requests, problems regarding Performance Measurement Network? Send feedback
This website is using cookies. More info. That's Fine